Hind.Bio Science

Hind.Bio_Science07 May 2024

Trading

₹

-0.27 (-3.18%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Hind.Bio Science

Hind.Bio Science

Trading

Hind.Bio_Science07 May 2024

₹

-0.27 (-3.18%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
12-Jan-2024	BC	HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation of Board Meeting to be h	31-Jan-2024
04-Dec-2023	BC	Board approved:- 1 The board of directors approved the notice of Extra Ordinary General Meeting of the members of the company to be held on 29' December, 2023 for the purpose of regularization of ad	29-Dec-2023
23-Nov-2023	BC	HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/12/2023 inter alia to consider and approve Intimation of Board Meeting for con	04-Dec-2023
19-Oct-2023	BC	HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Board Meeting Intimation Outcome	31-Oct-2023
31-Oct-2023	BC	Outcome of board meeting	31-Oct-2023

No Rights has been declared by Hind.Bio_Science

Book Closure

Record Date	Split Date	Purpose
31-Jan-2024	-	HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation of Board Meeting to be h
29-Dec-2023	-	Board approved:- 1 The board of directors approved the notice of Extra Ordinary General Meeting of the members of the company to be held on 29' December, 2023 for the purpose of regularization of ad
04-Dec-2023	-	HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/12/2023 inter alia to consider and approve Intimation of Board Meeting for con
31-Oct-2023	-	HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Board Meeting Intimation Outcome
31-Oct-2023	-	Outcome of board meeting

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Hindustan Bio Sciences Ltd ₹8.23(-0.27/-3.18%)	8.23	-0.27	8.44	1.55	411.50	12.22
Computer Point Ltd ₹4.96(+0.04/0.81%)	4.96	+0.04	14.88	143.56	496.00	0.45
Ambalal Sarabhai Enterprises Ltd ₹43.14(-1.74/-3.88%)	43.14	-1.74	330.60	99.02	0.00	9.08
Novartis India Ltd ₹1,065.55(+3.55/0.33%)	1,065.55	+3.55	2,630.93	77.73	27.54	3.75
Aegis Logistics Ltd ₹602.30(-1.55/-0.26%)	602.30	-1.55	21,140.73	52.10	47.92	9.52
Modella Woollens Ltd ₹70.31(-3.70/-5.00%)	70.31	-3.70	6.40	0.76	0.00	-69.62

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.32	0.32	0.00	0.33	0.32	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.32	0.32	0.00	0.33	0.32	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.01	0.01	0.00	0.00	0.00	0.00
Total Income	0.34	0.33	0.00	0.33	0.32	0.00
Total Expenditure	0.27	0.26	0.12	0.31	0.27	0.07
PBIDT	0.07	0.07	-0.12	0.02	0.05	-0.07
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.07	0.07	-0.12	0.02	0.05	-0.07
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.07	0.07	-0.12	0.01	0.05	-0.07
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.07	0.07	-0.12	0.01	0.05	-0.07

EPS (Unit Curr.)	0.07	0.06	-0.12	0.01	0.05	-0.07
EPS (Adj) (Unit Curr.)	0.07	0.06	-0.12	0.01	0.05	-0.07
Calculated EPS (Unit Curr.)	0.07	0.06	-0.12	0.01	0.05	-0.07
Calculated EPS (Adj) (Unit Curr.)	0.07	0.06	-0.12	0.01	0.05	-0.07
Calculated EPS (Ann.) (Unit Curr.)	0.27	0.26	-0.48	0.05	0.19	-0.29
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.27	0.26	-0.48	0.05	0.19	-0.29
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	2.05	2.05	2.05	2.05	10.25	10.25
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	21.88	21.88	0.00	6.06	15.63	0.00
PBDTM(%)	21.88	21.88	0.00	6.06	15.63	0.00
PATM(%)	21.88	21.88	0.00	3.03	15.63	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	2.05	10.25	10.25	10.25	10.25	10.25
Reserves Total	-1.30	-9.46	-8.95	-8.01	-8.09	-8.20
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	0.75	0.79	1.30	2.24	2.16	2.05
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	2.46	2.17	1.86	2.60	3.37	1.57
Total Debt	2.46	2.17	1.86	2.60	3.37	1.57
Total Liabilities	3.21	2.96	3.16	4.84	5.53	3.62
APPLICATION OF FUNDS :
Gross Block	0.55	0.55	0.54	0.54	0.54	0.54
Less : Accumulated Depreciation	0.51	0.51	0.50	0.49	0.48	0.48
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.04	0.04	0.04	0.05	0.06	0.06
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.34	0.11	0.08
Sundry Debtors	0.45	0.14	0.62	1.36	1.67	0.32
Cash and Bank	0.01	0.01	0.02	0.20	0.18	0.02
Loans and Advances	0.39	0.40	0.41	0.41	0.03	0.02
Total Current Assets	0.86	0.54	1.05	2.31	2.00	0.43
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.07	0.00	0.29	0.66	0.07	0.07
Provisions	0.02	0.02	0.03	0.06	0.04	0.02
Total Current Liabilities	0.09	0.03	0.32	0.71	0.10	0.09
Net Current Assets	0.77	0.51	0.72	1.59	1.90	0.34
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.01	0.01	0.01	0.03	0.03	0.03
Deferred Tax Liability	0.00	0.00	0.00	0.02	0.00	0.00
Net Deferred Tax	0.01	0.01	0.01	0.01	0.03	0.03
Total Assets	0.81	0.56	0.77	1.65	1.99	0.43
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.01	0.02	0.20	0.18	0.02
Net Cash from Operating Activities	-0.05	-0.34	0.75	0.82	-1.32
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.00	-0.01
Net Cash Used In Financing Activities	0.05	0.34	-0.93	-0.81	1.50
Net Inc./Dec In Cash And Cash Equivalents	0.00	-0.01	-0.18	0.01	0.17
Cash And Cash Equivalents At End Of The Year	0.01	0.01	0.02	0.20	0.18

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

12.19%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

87.81%

**Promoter pledged shareholding 12.19%

About Hindustan Bio Sciences Ltd

Hindustan Bio Sciences Ltd is in the Trading sector, having a market capitalization of Rs. 8.44 crores. It has reported a sales of Rs. 0.32 crores and a net profit of Rs. 0.07 crores for the quarter ended December 2018. The company management includes J.V.R. Mohan Raju, J.V.R. Mohan Raju,B R Rao,J Uma,K Rama Chandra Raju,M Satyanarayana Raju (Hindustan Bio Sciences Ltd) among others.

Chairman

J.V.R. Mohan Raju

Registered office

H No 8-2-269/S PlotNo 31 RdNo2,Sagar Co-Op Hous Banjara Hills,Hyderabad,Telangana,500034

FAX :

Background

Incorporation Year1991

Face Value₹2

Market Lot1

How to buy Hind.Bio Science shares on nse?

To buy Hind.Bio Science shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Hind.Bio Science share price today?

The Hind.Bio Science shares price on nse is Rs.8.23 today.

What is the market cap of Hind.Bio Science shares on BSE ?

The company has a market capitalization of Rs.8.44Cr

What is the PE & PB ratio of Hind.Bio Science shares ?

PE is 411.5 and PB is 12.22

What is the 52 Week High and Low of Hind.Bio Science shares?

Hind.Bio Science stock price high: Rs.15.18 Hind.Bio Science stock price low: Rs.5.15